2nd Quarter - Report

LUNDBECK LLC for LUNDBECK LLC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$201,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Apr 20, 2010 $201,000 Replaced
2nd Quarter - Report Jul 19, 2010 $214,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform, orphan drugs, 340b S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - pharmaceutical company fees S. 301 - Physician payments PDUFA Reauthorization Orphan Drug Act

Foreign entity interest: Assessing impact of health reform on patient access to medications and on US business.

LobbyistCovered position, as disclosed
MICHAEL J EGING —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3962 (111th), S. 525 (111th), H.R. 4872 (111th), H.R. 1298 (111th), S. 1796 (111th), H.R. 3590 (111th), H.R. 3200 (111th), S. 301 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.